Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| PCVX | +31.38% | +1.08% | −4.81% | +7.33% | +12.09% | +6.48% | +33.88% | +26.82% | +140.94% | +131.73% |
| DAOL-GIHEALTH | −0.11% | +4.57% | +7.34% | +0.56% | −4.73% | +5.35% | +3.26% | −3.15% | −43.60% | −46.03% |
| SCBIHEALTH(E) | +11.47% | +2.56% | +6.82% | +8.66% | +11.98% | +22.08% | +15.62% | +25.88% | −46.64% | −51.80% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes PCVX: money market or bond funds, or no holdings data yet
| DAOL-GIHEALTH | SCBIHEALTH(E) | |
|---|---|---|
| Held by both | ||
 Gilead Sciences | 4.79% | 5.08% |
 Vertex Pharmaceuticals | 3.48% | 4.83% |
 argenx | 4.28% | 3.12% |
| Only in DAOL-GIHEALTH | ||
 Revolution Medicines | 4.28% | N/A |
 Praxis Precision | 3.71% | N/A |
 Travere Therapeutics | 3.61% | N/A |
 BridgeBio Pharma | 3.51% | N/A |
| Only in SCBIHEALTH(E) | ||
 Eli Lilly and Co | N/A | 9.59% |
 Merck & | N/A | 6.49% |
 ABBVIE | N/A | 6.48% |
 AstraZeneca | N/A | 5.99% |
30 Dec 2025 → 2 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| SCBIHEALTH(E) | +11.47% | 17.39% | 0.66 |
| PCVX | +31.38% | 56.29% | 0.56 |
| DAOL-GIHEALTH | −0.11% | 18.52% | −0.01 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | PCVX | DAOL-GIHEALTH | SCBIHEALTH(E) |
|---|---|---|---|
Fund details | |||
| Fund size | N/A | 75.01 million | 30.22 million |
| Inception date | N/A | 28 May 2020 | 29 Jun 2021 |
| Master fund | N/A | Janus Henderson Horizon Biotechnology Fund | BNP Paribas Funds Health Care Innovators |
| Dividend policy | N/A | Does not pay | Does not pay |
Risk and currency hedging | |||
| Risk level | N/A | 7 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 77.55% | 82.39% |
Minimum purchase and redemption | |||
| First purchase | N/A | 1 THB | 1 THB |
| Subsequent purchase | N/A | 1 THB | 1 THB |
| Redemption (amount) | N/A | No minimum | 1 THB |
| Redemption (units) | N/A | No minimum | No minimum |
| Balance (amount) | N/A | No minimum | 1 THB |
| Balance (units) | N/A | 100 units | No minimum |
Order cut-off and redemption payment | |||
| Buy before | N/A | 15:00 | 15:30 |
| Redeem before | N/A | 15:00 | 15:30 |
| Redemption paid | N/A | T+4 | T+4 |
